Comparison of lidocaine and bronchodilator inhalation treatments for cough suppression in patients with chronic obstructive pulmonary disease

C. F. Chong, C. C. Chen, H. P. Ma, Y. C. Wu, Y. C. Chen, T. L. Wang

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Background: This study aimed to assess and compare the effectiveness of lidocaine and bronchodilator inhalation treatments for rapid cough suppression in patients with chronic obstructive pulmonary disease (COPD). Methods: Prospective comparison study carried out in a tertiary emergency department. Consecutive COPD patients presenting with intractable cough were randomly assigned to receive lidocaine or terbutaline inhalation treatments for cough suppression. Patients with dyspnoea, unstable vital signs, and pneumonia or neoplasm on chest x ray were excluded. A subjective, 10 point questionnaire based cough severity score was used for assessing the outcome. Results: The final study sample included 127 patients (mean (SD) age, 69.2 (12.1) years; 33.1% women) of whom 62 received nebulised lidocaine and 65 nebulised bronchodilator. The cough severity score was significantly reduced one hour after inhalation treatment with both lidocaine and bronchodilator, with no significant difference in efficacy. Common but mild side effects in the lidocaine group included oropharyngeal numbness and bitter taste, and, in the bronchodilator group, tremor and palpitation. Dyspnoea, dizziness, and nausea and vomiting were equally uncommon in both groups. None of these problems caused any of the patients to discontinue their treatments and no allergic reactions were reported. Conclusions: Both lidocaine and bronchodilator inhalation treatments are equally effective for short term cough suppression in patients with COPD.

Original languageEnglish
Pages (from-to)429-432
Number of pages4
JournalEmergency medicine journal : EMJ
Volume22
Issue number6
DOIs
Publication statusPublished - Jun 2005
Externally publishedYes

Fingerprint

Bronchodilator Agents
Lidocaine
Cough
Chronic Obstructive Pulmonary Disease
Inhalation
Dyspnea
Therapeutics
Terbutaline
Hypesthesia
Vital Signs
Dizziness
Tremor
Nausea
Vomiting
Hospital Emergency Service
Pneumonia
Hypersensitivity
Thorax
X-Rays
Prospective Studies

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Surgery
  • Nursing(all)
  • Emergency Medicine

Cite this

Comparison of lidocaine and bronchodilator inhalation treatments for cough suppression in patients with chronic obstructive pulmonary disease. / Chong, C. F.; Chen, C. C.; Ma, H. P.; Wu, Y. C.; Chen, Y. C.; Wang, T. L.

In: Emergency medicine journal : EMJ, Vol. 22, No. 6, 06.2005, p. 429-432.

Research output: Contribution to journalArticle

@article{13e61fc898304325b08408172e4698dd,
title = "Comparison of lidocaine and bronchodilator inhalation treatments for cough suppression in patients with chronic obstructive pulmonary disease",
abstract = "Background: This study aimed to assess and compare the effectiveness of lidocaine and bronchodilator inhalation treatments for rapid cough suppression in patients with chronic obstructive pulmonary disease (COPD). Methods: Prospective comparison study carried out in a tertiary emergency department. Consecutive COPD patients presenting with intractable cough were randomly assigned to receive lidocaine or terbutaline inhalation treatments for cough suppression. Patients with dyspnoea, unstable vital signs, and pneumonia or neoplasm on chest x ray were excluded. A subjective, 10 point questionnaire based cough severity score was used for assessing the outcome. Results: The final study sample included 127 patients (mean (SD) age, 69.2 (12.1) years; 33.1{\%} women) of whom 62 received nebulised lidocaine and 65 nebulised bronchodilator. The cough severity score was significantly reduced one hour after inhalation treatment with both lidocaine and bronchodilator, with no significant difference in efficacy. Common but mild side effects in the lidocaine group included oropharyngeal numbness and bitter taste, and, in the bronchodilator group, tremor and palpitation. Dyspnoea, dizziness, and nausea and vomiting were equally uncommon in both groups. None of these problems caused any of the patients to discontinue their treatments and no allergic reactions were reported. Conclusions: Both lidocaine and bronchodilator inhalation treatments are equally effective for short term cough suppression in patients with COPD.",
author = "Chong, {C. F.} and Chen, {C. C.} and Ma, {H. P.} and Wu, {Y. C.} and Chen, {Y. C.} and Wang, {T. L.}",
year = "2005",
month = "6",
doi = "10.1136/emj.2004.015719",
language = "English",
volume = "22",
pages = "429--432",
journal = "Emergency Medicine Journal",
issn = "1472-0205",
publisher = "BMJ Publishing Group",
number = "6",

}

TY - JOUR

T1 - Comparison of lidocaine and bronchodilator inhalation treatments for cough suppression in patients with chronic obstructive pulmonary disease

AU - Chong, C. F.

AU - Chen, C. C.

AU - Ma, H. P.

AU - Wu, Y. C.

AU - Chen, Y. C.

AU - Wang, T. L.

PY - 2005/6

Y1 - 2005/6

N2 - Background: This study aimed to assess and compare the effectiveness of lidocaine and bronchodilator inhalation treatments for rapid cough suppression in patients with chronic obstructive pulmonary disease (COPD). Methods: Prospective comparison study carried out in a tertiary emergency department. Consecutive COPD patients presenting with intractable cough were randomly assigned to receive lidocaine or terbutaline inhalation treatments for cough suppression. Patients with dyspnoea, unstable vital signs, and pneumonia or neoplasm on chest x ray were excluded. A subjective, 10 point questionnaire based cough severity score was used for assessing the outcome. Results: The final study sample included 127 patients (mean (SD) age, 69.2 (12.1) years; 33.1% women) of whom 62 received nebulised lidocaine and 65 nebulised bronchodilator. The cough severity score was significantly reduced one hour after inhalation treatment with both lidocaine and bronchodilator, with no significant difference in efficacy. Common but mild side effects in the lidocaine group included oropharyngeal numbness and bitter taste, and, in the bronchodilator group, tremor and palpitation. Dyspnoea, dizziness, and nausea and vomiting were equally uncommon in both groups. None of these problems caused any of the patients to discontinue their treatments and no allergic reactions were reported. Conclusions: Both lidocaine and bronchodilator inhalation treatments are equally effective for short term cough suppression in patients with COPD.

AB - Background: This study aimed to assess and compare the effectiveness of lidocaine and bronchodilator inhalation treatments for rapid cough suppression in patients with chronic obstructive pulmonary disease (COPD). Methods: Prospective comparison study carried out in a tertiary emergency department. Consecutive COPD patients presenting with intractable cough were randomly assigned to receive lidocaine or terbutaline inhalation treatments for cough suppression. Patients with dyspnoea, unstable vital signs, and pneumonia or neoplasm on chest x ray were excluded. A subjective, 10 point questionnaire based cough severity score was used for assessing the outcome. Results: The final study sample included 127 patients (mean (SD) age, 69.2 (12.1) years; 33.1% women) of whom 62 received nebulised lidocaine and 65 nebulised bronchodilator. The cough severity score was significantly reduced one hour after inhalation treatment with both lidocaine and bronchodilator, with no significant difference in efficacy. Common but mild side effects in the lidocaine group included oropharyngeal numbness and bitter taste, and, in the bronchodilator group, tremor and palpitation. Dyspnoea, dizziness, and nausea and vomiting were equally uncommon in both groups. None of these problems caused any of the patients to discontinue their treatments and no allergic reactions were reported. Conclusions: Both lidocaine and bronchodilator inhalation treatments are equally effective for short term cough suppression in patients with COPD.

UR - http://www.scopus.com/inward/record.url?scp=20344371951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20344371951&partnerID=8YFLogxK

U2 - 10.1136/emj.2004.015719

DO - 10.1136/emj.2004.015719

M3 - Article

VL - 22

SP - 429

EP - 432

JO - Emergency Medicine Journal

JF - Emergency Medicine Journal

SN - 1472-0205

IS - 6

ER -